Taligantinib
Taligantinib (Compound Example 70) is an orally active and selective dual inhibitor targeting vascular endothelial growth factor receptor 2 (VEGFR-2) and hepatocyte growth factor receptor (c-Met) . It effectively suppresses tumor angiogenesis and cell proliferation, and holds potential for the study of solid tumors such as non-small cell lung cancer and hepatocellular carcinoma.
Product Specifications
CAS Number
2243235-80-3
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
O=C (NC1=CC=C (F) C=C1) C2 (C (=O) NC3=CC=C (OC4=CC=NC5=CC (OCCCN6CCOCC6) =C7OCCOC7=C54) C (F) =C3) CC2
Molecular Formula
C35H34F2N4O7
Molecular Weight
660.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL506331V 500 µL Each
Dsg1c Mouse shRNA Lentiviral Particle (Locus ID 211924)
Sign In for Pricing
View Details 
MBS1753237-01 0.1 mg
Human VE Cadherin DyLight 488 Conjugated Antibody(Monoclonal, 3D4)
Sign In for Pricing
View Details MBS1753237-02 5x 0.1 mg
Human VE Cadherin DyLight 488 Conjugated Antibody(Monoclonal, 3D4)
Sign In for Pricing
View Details